Ironwood Pharmaceuticals, Inc. - Class A (IRWD) is a publicly traded Healthcare sector company. As of September 3, 2026, IRWD trades at $4.32 with a market cap of $728.71M and a P/E ratio of 5.41. IRWD moved -2.95% today. Year to date, IRWD is +0.47%; over the trailing twelve months it is +290.00%. Its 52-week range spans $0.53 to $5.78. Analyst consensus is buy with an average price target of $0.00. Rallies surfaces IRWD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for IRWD combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $4.32 |
| Market Cap | $728.71M |
| P/E Ratio | 5.41 |
| EPS | $0.80 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.78 |
| 52-Week Low | $0.53 |
| Volume | 911.53K |
| Avg Volume | 0 |
| Revenue (TTM) | $389.32M |
| Net Income | $129.87M |
| Gross Margin | 0.00% |
1 analysts cover IRWD: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $0.00.